Steven Nathan – 2022 could provide mixed investment performance 

Loading player...
10X founder Steven Nathan shares his rational opinion on several social and investment matters in the limelight. Mandatory vaccination, which many of the large South African corporations are implementing, is discussed. Nathan outlines that countries with relatively higher vaccination rates have seen a bigger uptick in economic growth than those with lower vaccination rates. He talks about the risks facing markets at the moment: lofty asset prices, inflation and the Omicron variant. Tencent’s investment into South African challenger bank TymeBank rounds off the conversation.  Learn more about your ad choices. Visit megaphone.fm/adchoices
8 Dec 2021 6AM English South Africa Investing · Business News

Other recent episodes

BNC#8: Melanie Veness on SA’s crisis - corruption, broken systems & a path forward

In a brutally honest keynote, Melanie Veness takes listeners to the frontline of South Africa’s economic crisis - where broken municipalities, failing infrastructure and political interference are no longer abstract problems, but daily battles. From chambers stepping in to fix water leaks and fight tariff abuse in court, to the…
24 Mar 7AM 22 min

BNC#8: Herman Mashaba on South Africa’s collapse - “Fix Johannesburg or lose everything!”

Speaking at BNC#8 in Hermanus, Herman Mashaba delivered a hard-hitting critique of South Africa’s collapsing governance, rising corruption, and eroding personal freedoms. From failing municipalities to unchecked crime, he argues the rule of law is under siege. Outlining bold reforms and his “Operation Fix Johannesburg,” Mashaba positions decisive leadership, accountability,…
24 Mar 5AM 21 min

Dr Kelvin Kemm: How “secure” is SA’s enriched uranium?

There are growing fears that nuclear weapons could be used in the Iran war. That has brought renewed focus on that 2007 attempted armed robbery at South Africa's nuclear research site, Pelindaba, and the “security” of the country’s large, high-quality enriched uranium stock. Chris Steyn asks Dr. Kelvin Kemm, a…
23 Mar 10AM 21 min